Maxwell V. Meng

10.7k citations

224 papers · 7.5k indexed · 1 hit paper · h-index 48

Impact in

Pulmonary and Respiratory Medicine top 0.2%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Renal and Vascular Pathologies
Urology top 0.5%
- Urological Disorders and Treatments

Papers in

Urology 25
- Urological Disorders and Treatments 22
Pulmonary and Respiratory Medicine 121
- Prostate Cancer Diagnosis and Treatment 50
- Renal cell carcinoma treatment 40
- Prostate Cancer Treatment and Research 40

Co-authors: Peter R. Carroll Marshall L. Stoller Matthew R. Cooperberg Jared M. Whitson Deborah P. Lubeck S. Mehta Katsuto Shinohara Sima P. Porten
Journals: The Journal of Urology (69 papers)Urology (32 papers)Journal of Clinical Oncology (18 papers)Urologic Oncology Seminars and Original Investigations (9 papers)British Journal of Urology (7 papers)
Partner nations: United States Canada Germany

In The Last Decade

Maxwell V. Meng

219 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer 2020 · 464 citations

Peers

Countries citing papers authored by Maxwell V. Meng

Since Specialization

Citations

This map shows the geographic impact of Maxwell V. Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxwell V. Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxwell V. Meng more than expected).

Fields of papers citing papers by Maxwell V. Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxwell V. Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxwell V. Meng. The network helps show where Maxwell V. Meng may publish in the future.

Co-authors

The 25 scholars most cited alongside Maxwell V. Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maxwell V. Meng Line = papers co-authored together Maxwell V. Meng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification and regulation of circulating tumor-TCR-matched cytotoxic CD4+ lymphocytes by KLRG1 in bladder cancer JCI Insight ·Serena S. Kwek, Hai Yang, Tony Li, Arielle Ilano, Eric D. Chow, Li Zhang, Pomerantz Ra, M. W. Holtrop, Averey Lea, Matthew Clark, Renata Monte, Yimin Shi, Elizabeth A. McCarthy, Sima P. Porten, Maxwell V. Meng, Chun Ye, Lawrence Fong, David Oh	2025	0
2	Readmissions trends following radical cystectomy for bladder cancer unchanged in the era of enhanced recovery after surgery (ERAS) protocols Urologic Oncology Seminars and Original Investigations ·Meera R. Chappidi, Jiaqi Liu, Maxwell V. Meng, Samuel L. Washington, Sima P. Porten	2023	3
3	Exhausted intratumoral Vδ2− γδ T cells in human kidney cancer retain effector function Nature Immunology ·Chiara Rancan, Marcel Arias-Badia, Pranay Dogra, Brandon Chen, Dvir Aran, Hai Yang, M. W. Holtrop, Arielle Ilano, Marino Marazzi, Pomerantz Ra, Serena S. Kwek, Li Zhang, Lewis L. Lanier, Maxwell V. Meng, Donna L. Färber, Lawrence Fong	2023	44
4	TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells European Urology Oncology ·Jonathan Chou, Katharina Hildisch, Martin Sjöström, Emily A. Egusa, Carissa Chu, Jun Zhu, Emily Chan, Ewan A. Gibb, Michelle L. Badura, Alberto Contreras‐Sanz, Bradley A. Stohr, Maxwell V. Meng, Raj S. Pruthi, Yair Lotan, Peter C. Black, Sima P. Porten, Vadim S. Koshkin, Terence W. Friedlander, Felix Y. Feng	2022	56
5	Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin Clinical Cancer Research ·Carissa Chu, Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu, Vadim S. Koshkin, Bradley A. Stohr, Maxwell V. Meng, Raj S. Pruthi, Terence W. Friedlander, Yair Lotan, Peter C. Black, Sima P. Porten, Felix Y. Feng, Jonathan Chou	2021	101
6	Metabolic imaging with hyperpolarized ¹³C pyruvate magnetic resonance imaging in patients with renal tumors—Initial experience Cancer ·Shuyu Tang, Maxwell V. Meng, James B. Slater, Jeremy W. Gordon, Daniel B. Vigneron, Bradley A. Stohr, Peder E. Z. Larson, Zhen J. Wang	2021	41
7	The Clinical Applications of Serum and Urinary Biomarkers in Prostate Cancer SHILAP Revista de lepidopterología ·Renu Eapen, Peter E. Lonergan, Д. К. Новиков, Sean Ong, Emelia Rahmawati, Nathan Lawrentschuk, Maxwell V. Meng	2020	2
8	lncRNA SNHG1 Promotes Progression of Cervical Cancer Through miR-195/NEK2 Axis SHILAP Revista de lepidopterología ·Gour Chand Mazumder, Maxwell V. Meng, Yun Miao	2020	1
9	Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy Urology ·Carissa Chu, Монастырев Владимир Дмитриевич, Jeffrey W. Liu, Tracy Kuo Lin, Candy Tsourounis, Rosa Rodríguez-Monguió, Ann Lazar, Samuel L. Washington, Matthew R. Cooperberg, Kirsten L. Greene, Peter R. Carroll, Raj S. Pruthi, Maxwell V. Meng, Lee‐lynn Chen, Sima P. Porten	2020	8
10	Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions Bladder Cancer ·Jeffrey W. Liu, Rebecca E. Graff, J L Bunch, Maxwell V. Meng, Sima P. Porten, Stacey A. Kenfield	2019	12
11	Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men Surgical Endoscopy ·Ahmed A. Hussein, Ogunmekan Go, Paul May, Maxwell V. Meng, Abolfazl Hosseini, Daniel Eun, Siamak Daneshmand, Bernard H. Bochner, James O. Peabody, Ronney Abaza, Eila C. Skinner, Richard E. Hautmann, Khurshid A. Guru	2018	12
12	Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes PLoS ONE ·Maurice M. Garcia, Alexander Gottschalk, Jonathan Brajtbord, Badrinath R. Konety, Maxwell V. Meng, Mack Roach, Peter R. Carroll	2014	17
13	Population‐based comparative effectiveness of nephron‐sparing surgery vs ablation for small renal masses British Journal of Urology ·Jared M. Whitson, Catherine R. Harris, Maxwell V. Meng	2012	47
14	Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance Journal of Clinical Oncology ·Sima P. Porten, Jared M. Whitson, Janet E. Cowan, Matthew R. Cooperberg, Katsuto Shinohara, Nannette Perez, Kirsten L. Greene, Maxwell V. Meng, Peter R. Carroll	2011	149
15	Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer Journal of Clinical Oncology ·Matthew R. Cooperberg, Janet E. Cowan, Joan F. Hilton, Adam C. Reese, Harras B. Zaid, Sima P. Porten, Katsuto Shinohara, Maxwell V. Meng, Kirsten L. Greene, Peter R. Carroll	2010	219
16	Changes in specific domains of sexual function and sexual bother after radical prostatectomy British Journal of Urology ·Jesse Le, Matthew R. Cooperberg, Natalia Sadetsky, Adam B. Hittelman, Maxwell V. Meng, Janet E. Cowan, David Latini, Peter R. Carroll	2010	40
17	Active surveillance for the management of prostate cancer in a contemporary cohort Cancer ·Marc Dall’Era, Badrinath R. Konety, Janet E. Cowan, Katsuto Shinohara, Keir Foss, Matthew R. Cooperberg, Maxwell V. Meng, Christopher J. Kane, G.V. Peregudov, Viraj A. Master, Peter R. Carroll	2008	300
18	Urinary Stone Disease Humana Press eBooks ·Marshall L. Stoller, Maxwell V. Meng, (unknown)	2007	88
19	Review of atypical pelvic masses on CT and MRI: expanding the differential diagnosis Clinical Imaging ·Peter Sulzer, Bonnie N. Joe, Maxwell V. Meng, Fergus V. Coakley, Benjamin M. Yeh	2007	8
20	Infections and Urinary Stone Disease Current Pharmaceutical Design ·Nadeem Rahman, Maxwell V. Meng, Marshall L. Stoller	2003	38

About Maxwell V. Meng

Maxwell V. Meng is a scholar working on Urology, Pulmonary and Respiratory Medicine, Surgery, Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health, having authored 224 papers that have together received 7.5k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (69 papers), Prostate Cancer Diagnosis and Treatment (50 papers), Renal cell carcinoma treatment (40 papers), Prostate Cancer Treatment and Research (40 papers), Urinary and Genital Oncology Studies (26 papers), Pediatric Urology and Nephrology Studies (23 papers), Urological Disorders and Treatments (22 papers) and Renal and related cancers (20 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.4k citations), Urology (835 citations), Surgery (2.8k citations), Oncology (1.4k citations) and Rheumatology (737 citations). Maxwell V. Meng has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Peter R. Carroll, Marshall L. Stoller, Matthew R. Cooperberg, Jared M. Whitson, Deborah P. Lubeck, S. Mehta, Katsuto Shinohara, Sima P. Porten, Janet E. Cowan and Kirsten L. Greene. Their work appears in journals such as The Journal of Urology, Urology, Journal of Clinical Oncology, Urologic Oncology Seminars and Original Investigations and British Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact